SMARTVACCINES

Smart Vaccine Depots

 Coordinatore ALBERT-LUDWIGS-UNIVERSITAET FREIBURG 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Germany [DE]
 Totale costo 164˙162 €
 EC contributo 149˙194 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-PoC
 Funding Scheme CSA-SA(POC)
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-11-01   -   2013-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ALBERT-LUDWIGS-UNIVERSITAET FREIBURG

 Organization address address: FAHNENBERGPLATZ
city: FREIBURG
postcode: 79085

contact info
Titolo: Prof.
Nome: Wilfried
Cognome: Weber
Email: send email
Telefono: +49 761 20397654

DE (FREIBURG) hostInstitution 149˙194.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

medical    patient    strategy    mainly    induce    vaccinations    human    proof    vaccines    diseases    depot    vaccination    attractive    vaccine    protection   

 Obiettivo del progetto (Objective)

'Vaccinations are a highly efficient and effective means for protecting humans and animals against severe diseases. For reaching an initial protective immune response, the vaccine must repeatedly be administered, mainly by injection. Omitting the repeated vaccine injections either due to the unavailability of medical personnel (mainly in developing countries) or due to negligence results in insufficient protection and susceptibility to disease. One solution for overcoming this lack in protection would be a vaccination strategy avoiding the need for additional appointments with medical personnel. This could be realized by the use of a vaccine depot that is injected together with the first vaccine dose. At a preset time point the patient would simply swallow a pill containing a trigger substance that would subsequently induce the release of the vaccine from the depot and induce the subsequent protection of the patient. In this project we will perform the proof of concept for the functionality of such a depot in animal models using vaccines against widespread infectious diseases like hepatitis B or human papilloma virus. With this study we aim at demonstrating the proof of concept that our newly developed materials can be applied to increase the patient compliance of vaccinations and thereby to increase the vaccination success rate. As our approach is likely generically applicable to different vaccines, we anticipate a highly attractive economical potential in the human medical and the veterinary fields. The scientific data obtained in this project together with a comprehensive market research and the development of a business strategy will shape a highly attractive commercial proposition for the successful valorization of our current ERC-funded research.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

ATOMION (2009)

Exploring hybrid quantum systems of ultracold atoms and ions

Read More  

GUDHI (2014)

Algorithmic Foundations of Geometry Understanding in Higher Dimensions

Read More  

SYSTEMSHOX.CH (2009)

A System Approach to Hox Genes Regulation in Vertebrates

Read More